FNF Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Fidelity National Financial Inc (FNF) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong financial performance, positive hedge fund activity, consistent dividend payouts, and favorable analyst ratings outweigh the current neutral technical indicators and lack of significant short-term trading signals.
The stock's technical indicators are neutral to slightly bearish. The MACD histogram is negative and contracting (-0.552), the RSI is neutral at 35.827, and the moving averages show a bearish trend (SMA_200 > SMA_20 > SMA_5). Key support is at $51.334, and resistance is at $54.333. The stock is trading near its support level, which could present a buying opportunity for long-term investors.
Hedge funds are significantly increasing their positions, with a 4793.94% increase in buying activity over the last quarter.
Strong financial performance in Q4 2025, with revenue up 11.82% YoY, net income up 34.59% YoY, and EPS up 37.11% YoY.
Consistent dividend payouts ($0.52 per share), reflecting stable cash flow and a commitment to rewarding shareholders.
Analysts maintain favorable ratings, with Keefe Bruyette raising the price target to $71 and an 'Outperform' rating.
Technical indicators are neutral to bearish, with no clear upward momentum.
Options data shows bearish short-term sentiment with a high put-call volume ratio of 11.
No recent congress trading data or significant insider activity to provide additional confidence.
Fidelity National Financial reported strong Q4 2025 results with adjusted pretax earnings of $401 million and $1.4 billion for the year. Revenue increased by 11.82% YoY to $4.029 billion, net income rose 34.59% YoY to $358 million, and EPS grew 37.11% YoY to $1.33. These results highlight strong growth trends and operational efficiency.
Analysts are generally positive on the stock. Keefe Bruyette raised the price target to $71 with an 'Outperform' rating, while Barclays adjusted its price target to $63 with an 'Equal Weight' rating, citing a better mortgage origination market and a benign credit environment in 2026.
